BB vs CORT · P/E 117, rev $549.1M vs P/E 199, rev $675.0M
BlackBerry Ltd (BB) versus Corcept Therapeutics Incorporated (CORT) — a side-by-side from cached financials, not a winner call.
BlackBerry Ltd (BB) is a software - infrastructure company listed on US.
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
Latest reported BB revenue for 2026-02-28 was $549.1M. Net income was $53.2M. Revenue was up 2.7% from 2025-02-28 to 2026-02-28. BB currently screens at market cap $6.14B and trailing P/E 116.5.
Latest reported CORT revenue for 2024-12-31 was $675.0M. Net income was $141.2M. Revenue was up 39.9% from 2023-12-31 to 2024-12-31. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
BB currently screens at market cap $6.14B and trailing P/E 116.5. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
Not investment advice. Open the BB and CORT stock pages for the full models.
Not investment advice.